1887

Abstract

The rat coronavirus sialodacryoadenitis virus (SDAV) causes respiratory infection and provides a system for investigating respiratory coronaviruses in a natural host. A viral suspension in the form of a microspray aerosol was delivered by intratracheal instillation into the distal lung of 6–8-week-old Fischer 344 rats. SDAV inoculation produced a 7 % body weight loss over a 5 day period that was followed by recovery over the next 7 days. SDAV caused focal lesions in the lung, which were most severe on day 4 post-inoculation (p.i.). Immunofluorescent staining showed that four cell types supported SDAV virus replication in the lower respiratory tract, namely Clara cells, ciliated cells in the bronchial airway and alveolar type I and type II cells in the lung parenchyma. In bronchial alveolar lavage fluid (BALF) a neutrophil influx increased the population of neutrophils to 45 % compared with 6 % of the cells in control samples on day 2 after mock inoculation. Virus infection induced an increase in surfactant protein SP-D levels in BALF of infected rats on days 4 and 8 p.i. that subsided by day 12. The concentrations of chemokines MCP-1, LIX and CINC-1 in BALF increased on day 4 p.i., but returned to control levels by day 8. Intratracheal instillation of rats with SDAV coronavirus caused an acute, self-limited infection that is a useful model for studying the early events of the innate immune response to respiratory coronavirus infections in lungs of the natural virus host.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.014282-0
2009-12-01
2020-10-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/12/2956.html?itemId=/content/journal/jgv/10.1099/vir.0.014282-0&mimeType=html&fmt=ahah

References

  1. Alcorn J. L., Stark J. M., Chiappetta C. L., Jenkins G., Colasurdo G. N. 2005; Effects of RSV infection on pulmonary surfactant protein SP-A in cultured human type II cells: contrasting consequences on SP-A mRNA and protein. Am J Physiol Lung Cell Mol Physiol 289:L1113–L1122 [CrossRef]
    [Google Scholar]
  2. Bhatt P. N., Percy D. H., Jonas A. M. 1972; Characterization of the virus of sialodacryoadenitis of rats: a member of the coronavirus group. J Infect Dis 126:123–130 [CrossRef]
    [Google Scholar]
  3. Crouch E. C. 2000; Surfactant protein-D and pulmonary host defense. Respir Res 1:93–108 [CrossRef]
    [Google Scholar]
  4. De Albuquerque N., Baig E., Ma X., Zhang J., He W., Rowe A., Habal M., Liu M., Shalev I. other authors 2006; Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J Virol 80:10382–10394 [CrossRef]
    [Google Scholar]
  5. Doss M., White M. R., Tecle T., Gantz D., Crouch E. C., Jung G., Ruchala P., Waring A. J., Lehrer R. I., Hartshorn K. L. 2009; Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D. J Immunol 182:7878–7887 [CrossRef]
    [Google Scholar]
  6. Fouchier R. A., Kuiken T., Schutten M., van Amerongen G., van Doornum G. J., van den Hoogen B. G., Peiris M., Lim W., Stohr K., Osterhaus A. D. 2003; Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423:240 [CrossRef]
    [Google Scholar]
  7. Franks T. J., Chong P. Y., Chui P., Galvin J. R., Lourens R. M., Reid A. H., Selbs E., McEvoy C. P., Hayden C. D. other authors 2003; Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 34:743–748 [CrossRef]
    [Google Scholar]
  8. Gagneten S., Scanga C. A., Dveksler G. S., Beauchemin N., Percy D., Holmes K. V. 1996; Attachment glycoproteins and receptor specificity of rat coronaviruses. Lab Anim Sci 46:159–166
    [Google Scholar]
  9. Gerna G., Campanini G., Rovida F., Percivalle E., Sarasini A., Marchi A., Baldanti F. 2006; Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J Med Virol 78:938–949 [CrossRef]
    [Google Scholar]
  10. Gerna G., Percivalle E., Sarasini A., Campanini G., Piralla A., Rovida F., Genini E., Marchi A., Baldanti F. 2007; Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients. J Clin Virol 38:244–250 [CrossRef]
    [Google Scholar]
  11. Grubor B., Gallup J. M., Meyerholz D. K., Crouch E. C., Evans R. B., Brogden K. A., Lehmkuhl H. D., Ackermann M. R. 2004; Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs. Clin Diagn Lab Immunol 11:599–607
    [Google Scholar]
  12. Haagsman H. P. 1998; Interactions of surfactant protein A with pathogens. Biochim Biophys Acta 1408:264–277 [CrossRef]
    [Google Scholar]
  13. Haagsman H. P., Hogenkamp A., van Eijk M., Veldhuizen E. J. 2008; Surfactant collectins and innate immunity. Neonatology 93:288–294 [CrossRef]
    [Google Scholar]
  14. Halbower A. C., Mason R. J., Abman S. H., Tuder R. M. 1994; Agarose infiltration improves morphology of cryostat sections of lung. Lab Invest 71:149–153
    [Google Scholar]
  15. Huang K. J., Su I. J., Theron M., Wu Y. C., Lai S. K., Liu C. C., Lei H. Y. 2005; An interferon-gamma-related cytokine storm in SARS patients. J Med Virol 75:185–194 [CrossRef]
    [Google Scholar]
  16. Johnston S. L. 2005; Overview of virus-induced airway disease. Proc Am Thorac Soc 2:150–156 [CrossRef]
    [Google Scholar]
  17. Kahn J. S., McIntosh K. 2005; History and recent advances in coronavirus discovery. Pediatr Infect Dis J 24:S223–S227 [CrossRef]
    [Google Scholar]
  18. Kahn J. S. 2006; The widening scope of coronaviruses. Curr Opin Pediatr 18:42–47
    [Google Scholar]
  19. Kesson A. M. 2007; Respiratory virus infections. Paediatr Respir Rev 8:240–248 [CrossRef]
    [Google Scholar]
  20. Khanolkar A., Hartwig S. M., Haag B. A., Meyerholz D. K., Harty J. T., Varga S. M. 2009; Toll-like receptor 4 deficiency increases disease and mortality after mouse hepatitis virus type 1 infection of susceptible C3H mice. J Virol 83:8946–8956 [CrossRef]
    [Google Scholar]
  21. Leth-Larsen R., Zhong F., Chow V. T., Holmskov U., Lu J. 2007; The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages. Immunobiology 212:201–211 [CrossRef]
    [Google Scholar]
  22. Ling T. Y., Kuo M. D., Li C. L., Yu A. L., Huang Y. H., Wu T. J., Lin Y. C., Chen S. H., Yu J. 2006; Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci U S A 103:9530–9535 [CrossRef]
    [Google Scholar]
  23. Mason R. J. 2006; Biology of alveolar type II cells. Respirology 11:SupplS12–S15 [CrossRef]
    [Google Scholar]
  24. Mason R. J., Lewis M. C., Edeen K. E., McCormick-Shannon K., Nielsen L. D., Shannon J. M. 2002; Maintenance of surfactant protein A and D secretion by rat alveolar type II cells in vitro. Am J Physiol Lung Cell Mol Physiol 282:L249–L258 [CrossRef]
    [Google Scholar]
  25. Miura T. A., Wang J., Mason R. J., Holmes K. V. 2006; Rat coronavirus infection of primary rat alveolar epithelial cells. Adv Exp Med Biol 581:351–356
    [Google Scholar]
  26. Miura T. A., Wang J., Holmes K. V., Mason R. J. 2007; Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines. Virology 369:288–298 [CrossRef]
    [Google Scholar]
  27. Mossel E. C., Wang J., Jeffers S., Edeen K. E., Wang S., Cosgrove G. P., Funk C. J., Manzer R., Miura T. A. other authors 2008; SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells. Virology 372:127–135 [CrossRef]
    [Google Scholar]
  28. Muller P. Y., Janovjak H., Miserez A. R., Dobbie Z. 2002; Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32:1372–1379
    [Google Scholar]
  29. Nagata N., Iwata N., Hasegawa H., Fukushi S., Yokoyama M., Harashima A., Sato Y., Saijo M., Morikawa S., Sata T. 2007; Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. J Virol 81:1848–1857 [CrossRef]
    [Google Scholar]
  30. Nicholls J. M., Poon L. L., Lee K. C., Ng W. F., Lai S. T., Leung C. Y., Chu C. M., Hui P. K., Mak K. L. other authors 2003; Lung pathology of fatal severe acute respiratory syndrome. Lancet 361:1773–1778 [CrossRef]
    [Google Scholar]
  31. Nicholls J. M., Butany J., Poon L. L., Chan K. H., Beh S. L., Poutanen S., Peiris J. S., Wong M. 2006; Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med 3:e27 [CrossRef]
    [Google Scholar]
  32. Nichols W. G., Peck Campbell A. J., Boeckh M. 2008; Respiratory viruses other than influenza virus: impact and therapeutic advances. Clin Microbiol Rev 21:274–290 [CrossRef]
    [Google Scholar]
  33. Parker J. C., Cross S. S., Rowe W. P. 1970; Rat coronavirus (RCV): a prevalent, naturally occurring pneumotropic virus of rats. Arch Gesamte Virusforsch 31:293–302 [CrossRef]
    [Google Scholar]
  34. Pastva A. M., Wright J. R., Williams K. L. 2007; Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc 4:252–257 [CrossRef]
    [Google Scholar]
  35. Peiris J. S., Lai S. T., Poon L. L., Guan Y., Yam L. Y., Lim W., Nicholls J., Yee W. K., Yan W. W. other authors 2003; Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319–1325 [CrossRef]
    [Google Scholar]
  36. Percy D. H., Williams K. L., Paturzo F. X. 1991; A comparison of the sensitivity and specificity of sialodacryoadenitis virus, Parker's rat coronavirus, and mouse hepatitis virus-infected cells as a source of antigen for the detection of antibody to rat coronaviruses. Arch Virol 119:175–180 [CrossRef]
    [Google Scholar]
  37. Rancourt R. C., Lee R. L., O'Neill H., Accurso F. J., White C. W. 2007; Reduced thioredoxin increases proinflammatory cytokines and neutrophil influx in rat airways: modulation by airway mucus. Free Radic Biol Med 42:1441–1453 [CrossRef]
    [Google Scholar]
  38. Reading P. C., Morey L. S., Crouch E. C., Anders E. M. 1997; Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol 71:8204–8212
    [Google Scholar]
  39. Roberts A., Deming D., Paddock C. D., Cheng A., Yount B., Vogel L., Herman B. D., Sheahan T., Heise M. other authors 2007; A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog 3:e5 [CrossRef]
    [Google Scholar]
  40. Shieh W. J., Hsiao C. H., Paddock C. D., Guarner J., Goldsmith C. S., Tatti K., Packard M., Mueller L., Wu M. Z. other authors 2005; Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Hum Pathol 36:303–309 [CrossRef]
    [Google Scholar]
  41. Sims A. C., Baric R. S., Yount B., Burkett S. E., Collins P. L., Pickles R. J. 2005; Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol 79:15511–15524 [CrossRef]
    [Google Scholar]
  42. Subbarao K., Roberts A. 2006; Is there an ideal animal model for SARS?. Trends Microbiol 14:299–303 [CrossRef]
    [Google Scholar]
  43. To K. F., Tong J. H., Chan P. K., Au F. W., Chim S. S., Chan K. C., Cheung J. L., Liu E. Y., Tse G. M. other authors 2004; Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J Pathol 202:157–163 [CrossRef]
    [Google Scholar]
  44. Vabret A., Dina J., Gouarin S., Petitjean J., Tripey V., Brouard J., Freymuth F. 2008; Human (non-severe acute respiratory syndrome) coronavirus infections in hospitalised children in France. J Paediatr Child Health 44:176–181 [CrossRef]
    [Google Scholar]
  45. van den Brand J. M., Haagmans B. L., Leijten L., van Riel D., Martina B. E., Osterhaus A. D., Kuiken T. 2008; Pathology of experimental SARS coronavirus infection in cats and ferrets. Vet Pathol 45:551–562 [CrossRef]
    [Google Scholar]
  46. van der Hoek L., Pyrc K., Jebbink M. F., Vermeulen-Oost W., Berkhout R. J., Wolthers K. C., Wertheim-van Dillen P. M., Kaandorp J., Spaargaren J., Berkhout B. 2004; Identification of a new human coronavirus. Nat Med 10:368–373 [CrossRef]
    [Google Scholar]
  47. Wang J., Oberley-Deegan R., Wang S., Nikrad M., Funk C. J., Hartshorn K. L., Mason R. J. 2009; Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN- λ 1) in response to influenza A infection. J Immunol 182:1296–1304 [CrossRef]
    [Google Scholar]
  48. Weiss S. R., Navas-Martin S. 2005; Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev 69:635–664 [CrossRef]
    [Google Scholar]
  49. WHO 2004 The World Health Report 2004: Changing History World Health Organization;
    [Google Scholar]
  50. Wojcinski Z. W., Percy D. H. 1986; Sialodacryoadenitis virus-associated lesions in the lower respiratory tract of rats. Vet Pathol 23:278–286
    [Google Scholar]
  51. Wong C. K., Lam C. W., Wu A. K., Ip W. K., Lee N. L., Chan I. H., Lit L. C., Hui D. S., Chan M. H. other authors 2004; Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136:95–103 [CrossRef]
    [Google Scholar]
  52. Woo P. C., Lau S. K., Chu C. M., Chan K. H., Tsoi H. W., Huang Y., Wong B. H., Poon R. W., Cai J. J. other authors 2005; Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79:884–895 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.014282-0
Loading
/content/journal/jgv/10.1099/vir.0.014282-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error